Dendritic Cell-Specific Delivery of Flt3L by Coronavirus Vectors Secures Induction of Therapeutic Antitumor Immunity

Abstract

Efficacy of antitumor vaccination depends to a large extent on antigen targeting to dendritic cells (DCs). Here, we assessed antitumor immunity induced by attenuated coronavirus vectors which exclusively target DCs in vivo and express either lymphocyte- or DC-activating cytokines in combination with a GFP-tagged model antigen. Tracking of in vivo transduced DCs revealed that vectors encoding for Fms-like tyrosine kinase 3 ligand (Flt3L) exhibited a higher capacity to induce DC maturation compared to vectors delivering IL-2 or IL-15. Moreover, Flt3L vectors more efficiently induced tumor-specific CD8+ T cells, expanded the epitope repertoire, and provided both prophylactic and therapeutic tumor immunity. In contrast, IL-2- or IL-15-encoding vectors showed a substantially lower efficacy in CD8+ T cell priming and failed to protect the host once tumors had been established. Thus, specific in vivo targeting of DCs with coronavirus vectors in conjunction with appropriate conditioning of the microenvironment through Flt3L represents an efficient strategy for the generation of therapeutic antitumor immunity.

Topological Small-World Organization of the Fibroblastic Reticular Cell Network Determines Lymph Node Functionality

“…Overall, analysis of these data indicated that substantial changes in intranodal T cell migration occurred when >70% of FRCs were lost, i.e., at DT doses of !2 ng/g. To assess how FRCs affect DC-mediated activation of antiviral CD8 + T cells, we resorted to a viral vector system that facilitates exclusive in vivo targeting of DCs [40,41]. Propagation-deficient coronavirus particles were injected subcutaneously into FRCdepleted mice, and the activation of antiviral CD8 + T cells was assessed in draining LNs.…”

The Reassessed Potential of SARS-CoV-2 Attenuation for COVID-19 Vaccine Development—A Systematic Review

“…As far as defects in innate immunity are concerned, only rather obscure models such as IFNAR1-deficient mice and TLR7-deficient mice were studied. Polymorphisms in those genes were associated with severe or unusual COVID-19 in humans, but it is unclear whether those models are truly relevant [ 70 , 96 , 150 , 151 ]. Inborn errors of acquired immunity are also associated with severe COVID-19 [ 152 ].…”

The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road

“…That same group also demonstrated that vectors encoding Flt3L, exhibited a higher capacity to induce DC maturation compared to vectors delivering IL-2 or IL-15. The former more efficiently induced tumor-specific CTLs with expanded epitope repertoire, resulting in therapeutic tumor immunity ( 146 ).…”